Degussa Spinout Elbion AG Draws EUR25M Series A Round
10/19/2005 5:12:27 PM
Elbion AG reeled in €25 million in Germany's first significant biotech financing of 2005. The company, which was formed through a management buyout of some of Degussa AG's pharmaceutical assets in 2002, concentrates on the discovery and development of small molecules that are effective against inflammatory and central nervous system diseases.
comments powered by